Common autoimmune drugs reduce mortality, up clinical status in COVID-19: NIH
By
Alicia Lasek (f3)
Jun 06, 2022
Two commonly used autoimmune drugs could be used in addition to standard-of-care treatments to improve COVID-19 outcomes, the agency says.
COVID-19 deaths among nursing home staff near all-time high
By
Amy Novotney
Jan 13, 2022
Deaths from COVID-19 among nursing home workers neared an all time high last week, according to a report released Wednesday by the American Health Care Association and National Center for Assisted Living.
New wave of flu cases, COVID-19 hospitalizations hits U.S., impacting seniors
By
Alicia Lasek
Dec 06, 2022
Flu activity was the highest in a decade last week and hospitalizations for three respiratory viruses are straining healthcare systems, CDC Director Rochelle Walensky said on Monday.
National survey tells story of COVID in assisted living
By
Alicia Lasek
Aug 19, 2021
New industry data from the CDC’s National Center for Health Statistics details how COVID-19 affected assisted living communities across the country during the height of the pandemic.
Clinical briefs for Tuesday, Sept. 21
By
Alicia Lasek
Sep 21, 2021
Humana reports rise in seniors’ COVID hospitalizations … Moderna shot leads pack at preventing COVID hospitalization, CDC finds … Experts unsure what flu has in store for this season … Drug combo...
‘A different phase’: End of COVID-19 vax rule for healthcare workers
By
Alicia Lasek
May 02, 2023
A COVID-19 vaccination rule for healthcare workers that took full effect after a Supreme Court vote in early 2022 will soon be lifted, the Biden administration says.
Moderna’s COVID vaccine tops 90% efficacy, can be refrigerated for 1 month
By
Alicia Lasek
Nov 17, 2020
Moderna’s trial vaccine will have big distribution advantages over Pfizer’s similarly successful candidate if both drugs are approved by the FDA.
WHO calls end to COVID-19 global health emergency
By
Alicia Lasek
May 08, 2023
It is time for the international community to recognize COVID-19 as an endemic disease and end the pandemic health emergency, the World Health Organization announced Friday.
The vaccine was most protective — at 90% efficacy — when participants received an initial half dose and then a full dose a month apart, the U.K. drugmaker says.
COVID-19 antiviral drug trials expected to wrap up within months: report
By
Alicia Lasek
Sep 27, 2021
Clinical trials for new COVID-19 antiviral drugs are expected to wrap up by winter, sparking hopes that a daily pill to treat COVID-19 infection is closer to fruition, according to a new report.